Screener
Opko Health OPK Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Opko Health’s 10-Q, filed July 27, 2026.
- Filed
- Jul 27, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-318090
| (In thousands) / Revenue from services: / Pharmaceutical | For the three months ended June 30, 2026 / — | For the three months ended June 30, 2025 / — | For the six months ended June 30, 2026 / — | For the six months ended June 30, 2025 / — |
|---|---|---|---|---|
| Pharmaceutical | $25,101 | $25,022 | $47,399 | $47,836 |
| Diagnostics | 58,462 | 82,383 | 114,604 | 166,901 |
| Corporate | — | — | — | — |
| $83,563 | $107,405 | $162,003 | $214,737 | |
| Gross margin: | ||||
| Pharmaceutical | $63,930 | $30,684 | $93,643 | $54,978 |
| Diagnostics | 16,087 | 18,718 | 32,131 | 37,044 |
| Corporate | — | — | — | — |
Item 1. Financial Statements
FAQ
- What is Opko Health's total cost of revenue?
- Opko Health (OPK) reported total cost of revenue of $83.56M in Q2 2026.
- How has Opko Health's total cost of revenue changed year-over-year?
- Opko Health's total cost of revenue decreased by 22.2% year-over-year, from $107.41M to $83.56M.
- What is the long-term trend for Opko Health's total cost of revenue?
- Over 3 years (2022 to 2025), Opko Health's total cost of revenue has grown at a -17.6% compound annual growth rate (CAGR), from $715.98M to $400.94M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about Opko Health's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude